Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

[Malignancies in HIV-infected patients: descriptive study of 129 cases between 1993 and 2010].

Meijide H, Mena A, Pernas B, Castro A, López S, Vázquez P, Bello L, Baliñas J, Rodríguez-Martínez G, Pedreira JD.

Rev Chilena Infectol. 2013 Apr;30(2):156-61. doi: 10.4067/S0716-10182013000200006. Spanish.

2.

Risk of cancers during interrupted antiretroviral therapy in the SMART study.

Silverberg MJ, Neuhaus J, Bower M, Gey D, Hatzakis A, Henry K, Hidalgo J, Lourtau L, Neaton JD, Tambussi G, Abrams DI.

AIDS. 2007 Sep 12;21(14):1957-63.

PMID:
17721103
3.

[Malignancies in HIV infected patients: study of 139 cases].

Ramírez-Olivencia G, Valencia-Ortega ME, Martin-Carbonero L, Moreno-Celda V, González-Lahoz J.

Med Clin (Barc). 2009 Nov 21;133(19):729-35. doi: 10.1016/j.medcli.2009.03.043. Spanish.

PMID:
19880148
4.

Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort.

Bruyand M, Thiébaut R, Lawson-Ayayi S, Joly P, Sasco AJ, Mercié P, Pellegrin JL, Neau D, Dabis F, Morlat P, Chêne G, Bonnet F; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA)..

Clin Infect Dis. 2009 Oct 1;49(7):1109-16. doi: 10.1086/605594.

5.

Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.

Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, De Weck D, Franceschi S; Swiss HIV Cohort..

J Natl Cancer Inst. 2005 Mar 16;97(6):425-32.

PMID:
15770006
6.

HIV-related malignancies pre- and post-highly active antiretroviral therapy: experiences in an inner city tertiary referral centre.

Kiely B, O'Flaherty J, Surah S, Kieran J, O'Donnell D, Bergin C, Mulcahy F.

Int J STD AIDS. 2010 May;21(5):332-6. doi: 10.1258/ijsa.2009.009486.

PMID:
20498102
7.

Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.

Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, Costagliola D, Salmon D, Chêne G, Morlat P.

Cancer. 2004 Jul 15;101(2):317-24.

8.

Characteristics of non-AIDS-defining malignancies in the HAART era: a clinico-epidemiological study.

Dauby N, De Wit S, Delforge M, Necsoi VC, Clumeck N.

J Int AIDS Soc. 2011 Mar 28;14:16. doi: 10.1186/1758-2652-14-16.

9.

Non-Hodgkin's lymphoma in patients with human immunodeficiency virus infection in Taiwan.

Yang CJ, Chen MY, Hsieh SM, Sheng WH, Sun HY, Hung CC, Chang SC.

J Microbiol Immunol Infect. 2010 Aug;43(4):278-84. doi: 10.1016/S1684-1182(10)60044-8.

10.

Malignancies in HIV: pre- and post-highly active antiretroviral therapy.

Nutankalva L, Wutoh AK, McNeil J, Frederick WR, Reddy RB, Daftary M, Gentles A, Addae-Afoakwa K.

J Natl Med Assoc. 2008 Jul;100(7):817-20.

PMID:
18672558
11.

Cancer survival in patients with HIV/AIDS in the era of highly active antiretroviral therapy in Taiwan: a population-based cohort study.

Lin CS, Lin C, Weng SF, Lin SW, Lin YS.

Cancer Epidemiol. 2013 Oct;37(5):719-24. doi: 10.1016/j.canep.2013.05.005.

PMID:
23770024
12.

Evolving epidemiology of malignancies in HIV.

Bonnet F, Chêne G.

Curr Opin Oncol. 2008 Sep;20(5):534-40. doi: 10.1097/CCO.0b013e32830a5080. Review.

PMID:
19106656
13.

Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.

Burgi A, Brodine S, Wegner S, Milazzo M, Wallace MR, Spooner K, Blazes DL, Agan BK, Armstrong A, Fraser S, Crum NF.

Cancer. 2005 Oct 1;104(7):1505-11.

14.

[Malignancy cases in HIV-positive patients in Lodz region in years 1992-2010].

Jabłonowska E, Małolepsza E, Strycharz M, Wójcik K.

Przegl Epidemiol. 2011;65(2):339-43. Polish.

PMID:
21913486
15.

HIV-associated monoclonal gammopathy: a retrospective analysis of 25 patients.

Amara S, Dezube BJ, Cooley TP, Pantanowitz L, Aboulafia DM.

Clin Infect Dis. 2006 Nov 1;43(9):1198-205.

PMID:
17029142
16.

Ten-year survival among HIV-1-infected subjects with AIDS or non-AIDS-defining malignancies.

Spagnuolo V, Galli L, Salpietro S, Gianotti N, Guffanti M, Cossarini F, Bigoloni A, Cinque P, Bossolasco S, Travi G, Fumagalli L, Lazzarin A, Castagna A.

Int J Cancer. 2012 Jun 15;130(12):2990-6. doi: 10.1002/ijc.26332.

17.

Ten years later: a single hospital experience with malignancy in HIV/AIDS.

Reed M, Cosgrove JM, Cindrich R, Parithivel VS, Gad Y, Bangalore M, Uzor R, Kalim J, Segura R, Albu E.

J Surg Oncol. 2010 Sep 1;102(3):282-6. doi: 10.1002/jso.21590.

PMID:
20740588
19.

Malignancies in HIV-infected Thai patients.

Kiertiburanakul S, Likhitpongwit S, Ratanasiri S, Sungkanuparph S.

HIV Med. 2007 Jul;8(5):322-3.

20.

[Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].

Jacomet C, Lesens O, Villemagne B, Darcha C, Tournilhac O, Henquell C, Cormerais L, Gourdon F, Peigue-Lafeuille H, Travade P, Beytout J, Laurichesse H.

Med Mal Infect. 2006 Mar;36(3):157-62. French.

PMID:
16503104

Supplemental Content

Support Center